News & Blog
ENDPOINT NEWS EXCLUSIVE: Sanofi, Astellas venture arms add cash to Avilar’s ‘ATAC’ mission
Looking Ahead Series: Insights on Innovation from the MEC Council and the Brightest Minds
AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS
Medical Excellence Foundation Announces First MERIT Grant
Endpoints News: A stem cell pioneer sent an experiment into space. Patients are the next frontier
Our Sophomore Year: A Review of 2022
BioCentury: BioCentury’s 2022 class of emerging companies
Looking Ahead Series: Developing Insights from the MEC Council and the Brightest Minds
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
Aspen Neuroscience Inks $40 Million Debt Deal with Silicon Valley Bank